Disclosed are methods, compounds, and compositions for treating infection by an Apicomplexan parasite that include administering a compound that selectively inactivates ornithine aminotransferase of the Apicomplexan parasite. Specifically, the methods, compounds, compounds may be utilized for treating infection by
Toxoplasma gondii
and toxoplasmosis and for treating infection by
Plasmodium falciparum
and malaria. The compounds disclosed herein are observed to selectively inactivate
Toxoplasma gondii
ornithine aminotransferase (TgOAT) relative to human OAT and relative to human γ-aminobutyric aminotransferase (GABA-AT).
揭示了一种治疗具有选择性灭活裂殖孢子虫的鸟
氨基转移酶的化合物、方法和组合物。具体来说,这些方法、化合物可用于治疗弓形虫和弓形虫病感染,以及治疗疟原虫和疟疾感染。本文披露的化合物被观察到相对于人类鸟
氨基转移酶和人类γ-
氨基
丁酸氨基转移酶(
GABA-AT)具有选择性地灭活弓形虫鸟
氨基转移酶(TgOAT)。